You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Norris Medicines Ltd"

Norris Medicines Ltd Board Meeting Intimation for To Consider Audited Financial Results For The Quarter And Year Ended O

  • 16/05/2022
  • |
  • bse

Norris Medicines Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate

  • 20/04/2022
  • |
  • bse

Norris Medicines Ltd Submission Of Certificate Under Reg. 40(9) For The Period Ended March 31 2021

  • 20/04/2022
  • |
  • bse

Norris Medicines Ltd Submission Of Certificate Under Regulation 7(3) For The Period Ended 31St March 2022

  • 11/04/2022
  • |
  • bse

Norris Medicines Ltd Statement Of Investor Complaints For The Quarter Ended March 2022

  • 05/04/2022
  • |
  • bse

Norris Medicines Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 05/04/2022
  • |
  • bse

Norris Medicines Ltd Closure of Trading Window

  • 31/03/2022
  • |
  • bse

Norris Medicines Ltd Revision In Policy On Materiality Of Events & Its Disclosures

  • 13/02/2022
  • |
  • bse

Norris Medicines Ltd Standalone Unaudited Financial Results In Compliance<BR> With Regulation 33 Of SEBI (LODR) RegUlatio

  • 12/02/2022
  • |
  • bse

Norris Medicines Ltd Board Meeting Outcome for Outcome Of Board Meeting

  • 12/02/2022
  • |
  • bse

Norris Medicines Ltd Board Meeting Intimation for Consider And Approval Of Unaudited Standalone Financial Results Of The

  • 02/02/2022
  • |
  • bse

Norris Medicines Ltd Shareholding for the Period Ended December 31 2021

  • 13/01/2022
  • |
  • bse

Norris Medicines Ltd Statement Of Investor Complaints For The Quarter Ended December 2021

  • 06/01/2022
  • |
  • bse

Norris Medicines Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 06/01/2022
  • |
  • bse

Norris Medicines Ltd Closure of Trading Window

  • 31/12/2021
  • |
  • bse

Norris Medicines Ltd Submission Of Standalone Unaudited Financial Results In Compliance With Regulation 33 Of SEBI (LODR)

  • 12/11/2021
  • |
  • bse

Norris Medicines Ltd Board Meeting Outcome for Outcome Of Board Meeting <BR>

  • 12/11/2021
  • |
  • bse

Norris Medicines Ltd Board Meeting Intimation for Approval Of Unaudited Standalone Financial Results Of The Company For T

  • 30/10/2021
  • |
  • bse

Norris Medicines Ltd Shareholding for the Period Ended September 30 2021

  • 20/10/2021
  • |
  • bse

Norris Medicines Ltd Statement Of Investor Complaints For The Quarter Ended September 2021

  • 04/10/2021
  • |
  • bse
.